Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients

NCT00000733 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Ribavirin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)